Asthmatics, compared to nonasthmatic controls, had higher prevalence of SPT reactivity, ImmunoCAP® IgE sensitization, dermatitis and rhinitis, and higher total IgE levels (Table 1). This evidence concerns the gene IGHE and rhinitis.